Close

Spectrum Pharmaceuticals, Inc. (SPPI) Posts Mixed Q2 Results

August 4, 2011 7:52 AM EDT
Spectrum Pharmaceuticals, Inc. (NASDAQ: SPPI) reported Q2 EPS of $0.12, $0.03 worse than the analyst estimate of $0.15. Revenue for the quarter came in at $45.5 million versus the consensus estimate of $37.25 million.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings